INSP · NYSE
Inspire Medical Systems (INSP) Stock Price & Fundamentals
Inspire Medical Systems (INSP) closed at $507.11 on Oct 9, 2026, up 0.78% from the previous close of $503.21.
Share price, past year
1Y +25.07%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $507.11 |
| Sep 30, 2026 | $500.76 |
| Aug 31, 2026 | $504.63 |
| Jul 31, 2026 | $479.14 |
| Jun 30, 2026 | $439.54 |
| May 29, 2026 | $418.54 |
| Apr 30, 2026 | $399.14 |
| Mar 31, 2026 | $414.99 |
| Feb 27, 2026 | $391.31 |
| Jan 30, 2026 | $406.34 |
| Dec 31, 2025 | $413.07 |
| Nov 28, 2025 | $404.64 |
| Oct 31, 2025 | $405.42 |
Key statistics
- Market cap
- $14.66B
- P/E (TTM)
- 111.9
- EPS (TTM)
- $4.53
- Revenue (TTM)
- $898.74M
- Net income (TTM)
- $135.04M
- Shares outstanding
- 28.9M
- Dividend yield
- —
- 52-week range
- $383.21 – $509.36
Inspire Medical Systems's market cap is $14.66B, based on a share price of $507.11 and 28.9M shares outstanding as of Jun 30, 2026.
Financials
Inspire Medical Systems reported revenue of $911.98M for fiscal 2025, up 13.60% from fiscal 2024.
Inspire Medical Systems earned net income of $145.42M in fiscal 2025, a net margin of 15.9%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $911.98M | +13.6% | $145.42M | 16.0% | $4.89 | $78.48M |
| FY2024ended Dec 31, 2024 | $802.80M | +28.5% | $53.51M | 6.7% | $1.75 | $91.12M |
| FY2023ended Dec 31, 2023 | $624.80M | +53.2% | −$21.15M | −3.4% | −$0.72 | $1.02M |
| FY2022ended Dec 31, 2022 | $407.86M | +74.8% | −$44.88M | −11.0% | −$1.60 | $2.47M |
| FY2021ended Dec 31, 2021 | $233.39M | +102.3% | −$42.04M | −18.0% | −$1.54 | −$24.79M |
| FY2020ended Dec 31, 2020 | $115.38M | +40.6% | −$57.20M | −49.6% | −$2.19 | −$55.50M |
| FY2019ended Dec 31, 2019 | $82.05M | +62.2% | −$33.24M | −40.5% | −$1.40 | −$35.59M |
| FY2018ended Dec 31, 2018 | $50.59M | +77.1% | −$21.83M | −43.1% | −$1.50 | −$18.94M |
| FY2017ended Dec 31, 2017 | $28.57M | +73.9% | −$17.51M | −61.3% | −$14.88 | −$16.20M |
| FY2016ended Dec 31, 2016 | $16.43M | — | −$18.53M | −112.8% | −$16.90 | −$18.26M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $200.58M | $314.00K | $0.01 |
| Q1 FY2026ended Mar 31, 2026 | $204.58M | −$11.29M | −$0.39 |
| Q4 FY2025ended Dec 31, 2025 | $269.08M | $136.09M | $4.57 |
| Q3 FY2025ended Sep 30, 2025 | $224.50M | $9.93M | $0.34 |
| Q2 FY2025ended Jun 30, 2025 | $217.09M | −$3.59M | −$0.12 |
| Q1 FY2025ended Mar 31, 2025 | $201.32M | $2.99M | $0.10 |
| Q4 FY2024ended Dec 31, 2024 | $239.72M | $35.22M | $1.17 |
| Q3 FY2024ended Sep 30, 2024 | $203.19M | $18.50M | $0.60 |
Company profile
- Name
- Inspire Medical Systems, Inc.
- Ticker
- INSP
- Exchange
- NYSE
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 5500 Wayzata Blvd, Suite 1600, Golden Valley, MN 55416
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001609550
Recent SEC filings
- Aug 3, 2026
- Aug 3, 2026
- Jul 24, 2026
- Jul 22, 2026
- Jun 26, 2026
- May 5, 2026
- May 4, 2026
- May 4, 2026
Frequently asked questions
What is Inspire Medical Systems's stock price?
Inspire Medical Systems (INSP) closed at $507.11 on Oct 9, 2026, up 0.78% from the previous close of $503.21.
What is Inspire Medical Systems's market cap?
Inspire Medical Systems's market cap is $14.66B, based on a share price of $507.11 and 28.9M shares outstanding as of Jun 30, 2026.
How much revenue does Inspire Medical Systems make?
Inspire Medical Systems reported revenue of $911.98M for fiscal 2025, up 13.60% from fiscal 2024.
What is INSP's P/E ratio?
Inspire Medical Systems's price-to-earnings ratio is 111.9, based on trailing twelve-month diluted EPS of $4.53.
Does Inspire Medical Systems pay a dividend?
Inspire Medical Systems's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Inspire Medical Systems, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures